Summary

Dr. Jasmine (Talameh) Luzum, PharmD, PhD, BCPS joined the Department of Clinical Pharmacy in the College of Pharmacy in July 2016. She received her PharmD summa cum laude from the University of Pittsburgh in 2008 and her PhD in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill Eshelman School of Pharmacy in 2013. She completed a Post-Doctoral Fellowship at the Ohio State University College of Medicine and Center for Pharmacogenomics in 2016. She became a Board-Certified Pharmacotherapy Specialist by the Board of Pharmacy Specialties and an Applied Pharmacologist by the American Board of Clinical Pharmacology in 2015.

Dr. Luzum’s long-term goal is to improve pharmacologic outcomes and reduce racial disparities in patients with cardiovascular disease, especially heart failure. She works to accomplish that goal using a variety of clinical & translational research approaches, with an emphasis on pharmacogenomics and bioinformatics. Her research has been funded by the most prestigious sponsors (e.g., NIH, American Heart Association, and American Foundation for Pharmaceutical Education), published in top journals (e.g., Cell Metabolism, Clinical Pharmacology & Therapeutics, Journal of the American Heart Association), and presented at major conferences (e.g., American College of Cardiology Scientific Sessions and the NIH Pharmacogenomics Research Network).   

Research Interests

  • Cardiovascular pharmacogenetics

    Beta-blocker efficacy and toxicity in patients with heart failure
    Statin efficacy and toxicity

  • Modeling approaches for multiple pharmacogenetic markers

    Systems biology/bioinformatics
    Machine learning
    Physiologically based pharmacokinetic modeling

  • Implementation of pharmacogenomics into clinical practice

    Clinical pharmacogenetics service and workflow
    Clinical pharmacogenetic education
    Cost effectiveness and reimbursement